Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Annual progress in the clinical management and research of bronchiectasis 2025].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2026
Same author

[A consistency comparison between next-generation sequencing and the FISH method for gene rearrangement detection in B-cell lymphomas].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024
Same author

[Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2022
Same author

[Subcutaneous sparganosis: a case report].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2021
Same author

[Clinicopathological features and molecular genetics of Burkitt-like lymphoma with 11q aberration].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2021
Same author

Effects of combined therapy of valsartan and rosuvastatin on patients with atrial fibrillation.

Journal of biological regulators and homeostatic agents·2020
Same journal

Polyfunctional Thiazole/Thiazolidinone Derivatives as a New Class of Heterocyclic Compounds with Novel Mechanisms of Anticancer Activity.

Experimental oncology·2026
Same journal

Metabolic Inhibitors and their Impact on Cancer Cell Migration, Invasion, and Metastasis.

Experimental oncology·2026
Same journal

Changes in Cytokine Profile of Macrophages Induced by Chronic Stress in intact and tumor-bearing rats.

Experimental oncology·2026
Same journal

Integrated Analysis of hsa-miR-26b-5p and hsa-miR-186-5p in Blood Serum and Tumor Tissue Reveals their Prognostic and Predictive Significance in Breast Cancer.

Experimental oncology·2026
Same journal

FNBP1 in Chronic Myeloid Leukemia: Spatial Association with BCR-ABL and Potential Implications for Targeted Therapy.

Experimental oncology·2026
Same journal

Stress-Induced Changes in the Methylation Status of Mmp1 and Mmp8 Genes in Tumor Tissue of Rats with Guerin Carcinoma.

Experimental oncology·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

Accelerated cellular senescence in solid tumor therapy.

P C Wu1, Q Wang, L Grobman

  • 1Department of Surgery, VA Puget Sound Health Care System, Seattle, WA 98108, USA. pcwu@uw.edu

Experimental Oncology
|October 17, 2012
PubMed
Summary
This summary is machine-generated.

Accelerated cellular senescence (ACS) involves cell cycle arrest in cancer cells. Some cells escape this arrest, driving cancer progression, highlighting the need for senescence-based therapies.

More Related Videos

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

Related Experiment Videos

Last Updated: May 17, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
08:57

Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies

Published on: September 19, 2025

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Accelerated cellular senescence (ACS) is a state of sustained, telomere-independent cell cycle arrest.
  • Neoplastic cells undergo ACS in response to chemotherapy, radiation, oxidative stress, or oncogenic stimuli.
  • A subset of tumor cells can escape ACS, leading to cancer progression.

Purpose of the Study:

  • To review the current understanding of accelerated cellular senescence.
  • To explore signaling pathways involved in senescence escape.
  • To discuss the role of senescence biomarkers and the rationale for senescence-based therapies.

Main Methods:

  • This is a review article.
  • It synthesizes current evidence on accelerated cellular senescence.
  • It focuses on signaling pathways, biomarkers, and therapeutic strategies.

Main Results:

  • Evidence suggests that reversible ACS can be escaped by tumor cells.
  • Senescence escape contributes to cancer progression.
  • Understanding these mechanisms is crucial for developing new treatments.

Conclusions:

  • Accelerated cellular senescence is a complex process with implications for cancer therapy.
  • Targeting senescence escape pathways and utilizing senescence biomarkers are promising therapeutic avenues.
  • Further research into senescence-based therapies is warranted.